eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiology

Ventricular Septal Defect, General Concepts: Follow-up

Author: Prema Ramaswamy, MD, Assistant Professor of Pediatrics, Mount Sinai School of Medicine of New York University; Adjunct Assistant Clinical Professor of Pediatrics, St George's University School of Medicine; Co-Director of Pediatric Cardiology, Maimonides Medical Center, Lutheran Medical Center, and Coney Island Hospital
Coauthor(s): Patturajah Anbumani, MD, MBBS, MS, MCh, Associate Medical Director, Best Medical Care; Former Associate Medical Director, Jeanes Hospital, Temple University Health System; Former Adjunct Clinical Assistant Professor, New York College of Osteopathic Medicine; Former Clinical Assistant Professor, Department of Medicine, State University of New York-Downstate; Kuruchi Srinivasan, MD, Consulting Staff, Department of Internal Medicine, Nazareth Hospital
Contributor Information and Disclosures

Updated: Feb 10, 2009

Follow-up

Further Outpatient Care

  • Even patients with small ventricular septal defects (VSDs) require indefinite follow-up.
  • Patients with perimembranous ventricular septal defects who have undergone aneurysmal closure have a high incidence of left ventricular (LV)-to-right atrial (RA) shunts and a 6% incidence of subaortic ridge as shown in a large Chinese study.6
  • Emphasize the importance of good dental hygiene and prophylactic antibiotics for infective endocarditis.
  • With increasing age, the incidence of aortic leaflet prolapse and aortic insufficiency increases in children with the doubly committed and perimembranous type of ventricular septal defect.

Complications

  • Eisenmenger complex
    • Eisenmenger complex is the most severe complication.
    • Fixed and irreversible pulmonary hypertension develops, resulting in reversal of the left-to-right shunt to a right-to-left shunt.
  • Secondary aortic insufficiency
    • Secondary aortic insufficiency is associated with prolapse of aortic valve leaflets.
    • This is rare in children younger than 2 years.
    • This complication is observed only in 5% of patients with ventricular septal defect.
    • The incidence is higher in supracristal ventricular septal defects than in perimembranous ventricular septal defects.
  • Aortic regurgitation
    • The development of aortic regurgitation in association with doubly committed subarterial ventricular septal defect is a well-known phenomenon.
    • Aortic regurgitation is due to a poorly supported right coronary cusp combined with the Venturi effect produced by the ventricular septal defect jet, resulting in cusp prolapse.
  • RV outflow tract obstruction
    • Right ventricular (RV) outflow tract obstruction was noted in 7% of a large cohort of ventricular septal defect in France.18  The investigators noted the obstruction to be infundibular.
    • A later angiocardiographic study showed that the obstruction was most often secondary to anomalous muscle bundles and only rarely infundibular.19
  • Subaortic obstruction
    • Discrete fibrous subaortic stenosis is occasionally associated with a ventricular septal defect.
    • This complication is most often reported with perimembranous ventricular septal defects and can first appear after either spontaneous or surgical closure.
    • Zielinsky et al concluded that anterior or posterior malalignment of the outlet or the conal septum is present in all patients with a ventricular septal defect who develop discrete subaortic stenosis.20
  • Infective endocarditis
    • Infective endocarditis is rare in children younger than 2 years.
    • In the presence of infective carditis in pulmonary circulation, meticulously record the patient's history and echocardiographically investigate the left-to-right shunt. In ventricular septal defects, both the systemic and pulmonary circulation may be affected; hence, vegetation manifests on both sides.
    • Embolization is highly expected despite the morphology of the vegetation. In general, vegetation more than 10 mm, particularly if pedunculated, should be regarded as an indication for surgical intervention, even in the absence of symptoms.
    • Infection is usually located at the ridge of the ventricular septal defect itself or the tricuspid leaflet.

Prognosis

  • The current surgical mortality rate is less than 2% for isolated ventricular septal defects.
  • Children with small ventricular septal defects are asymptomatic and have excellent long-term prognoses.
  • The outcome of medical therapy for children with moderate or large ventricular septal defects is as follows:
    • Many infants improve, showing evidence of a gradual decrease in the magnitude of the left-to-right shunt when aged 6-24 months. Carefully assessing the cause of the decrease in left-to-right flow, which can reflect an increase in pulmonary vascular resistance (PVR), a decrease in the relative size of the defect, or the development of RV outflow tract hypertrophy, resulting in functional or anatomic obstruction.
    • Most children with ventricular septal defect remain in stable condition or improve after infancy. Heart failure rarely occurs after infancy. Anemia, respiratory infection, endocarditis, or the development of an associated lesion (eg, aortic insufficiency) can trigger a recurrence of symptoms.
  • A few patients who develop severe pulmonary vascular obstructive disease with predominant right-to-left shunts (Eisenmenger syndrome) at the time of referral require symptomatic therapy.
    • Cyanosis progressively increases, and exercise capacity decreases.
    • RBC reduction by means of partial-exchange transfusion may relieve symptoms associated with extreme polycythemia (eg, headache, extreme fatigue).
    • Select patients may be candidates for lung or heart-lung transplantation.

Patient Education

  • Lifestyle changes (ie, exercise before and after surgery or catheterization) may not be required.
    • A restrictive ventricular septal defect with a functional normal heart imposes no exercise limitation.
    • Although patients can safely participate in competitive sports without restriction, adults in this category are uncommon. An important exception is the adult whose moderately restrictive perimembranous ventricular septal defect decreased in size or closed spontaneously in infancy. However, 2-dimensional echocardiography with Doppler interrogation and color flow imaging should be performed to determine whether the defect closed by means of formation of a septal aneurysm.
  • Unrestricted exercise after surgical closure of a moderate-to-large ventricular septal defect is permitted if the following criteria are met:
    • Postoperative PA pressure
    • Absence of clinically significant disturbances in ventricular rhythm during maximal exercise stress testing and during 24-hour ambulatory electrocardiography
    • Two-dimensional echocardiographic evidence of an intact ventricular septum with normalization of LV and LA size and LV function
    • Twelve-lead scalar ECG revealing little or no evidence of LV volume overload or RV pressure overload
  • For excellent patient education resources, visit eMedicine's Heart Center. Also, see eMedicine's patient education articles Tetralogy of Fallot and Ventricular Septal Defect.

Miscellaneous

Medicolegal Pitfalls

  • Failure to distinguish pathologic murmur of ventricular septal defect (VSD) from innocent physiologic murmurs
  • Failure to recognize subtle signs and symptoms of ventricular septal defect
  • Failure to detect ventricular septal defect early and to refer patient for surgical repair to prevent complications, including the onset of pulmonary vascular disease

Special Concerns

  • Pregnancy and prenatal care
    • The presence or lack of early care is not a factor in congenital cardiovascular malformations (CCVMs).
    • A major objective of medical management is to minimize the factors that interfere with the limited circulatory reserve of pregnant women with ventricular septal defects.
    • Because anxiety is a special concern in a primigravida, the expectant mother should be prepared mentally for pregnancy, labor, delivery, and puerperium.
    • Diuretics can be used judiciously to manage edema of cardiac failure, but they should not be used to treat edema of normal pregnancy.
    • Pregnant women with heart disease should limit themselves to moderate isotonic exercise.
    • Maternal mortality in pregnant women with heart disease has been associated with the functional class.
    • Ventricular septal defect associated with pulmonary vascular disease is one of the 2 major maternal cardiac risks; the other is pulmonary edema.
  • Labor and delivery
    • In women with functionally mild unoperated lesions and in patients after successful surgical repair, management of labor and delivery is the same as for pregnant women without a ventricular septal defect.
    • The recommendations of the American Heart Association state that no antibiotic prophylaxis is required for a normal vaginal delivery.
    • For pregnant women with functionally important congenital cardiac disease (unoperated or operated), the management of labor, delivery, and the puerperium is crucial to minimize risk.
    • Induced vaginal delivery is preferred over cesarean delivery. Cesarean delivery results in twice the blood loss of vaginal delivery. In addition, it is associated with risks of wound infection, uterine infection, thrombophlebitis, and potential postoperative complications.
  • Effect of CCVM on society
    • Cardiovascular malformations are the leading cause of premature mortality from congenital anomalies.
    • The progressive reduction in the mortality rate over the past 20 years reflects the major advances in the management of heart defects in infants.
    • Premature mortality computed as years of potential life lost before age 65 years is a way of measuring the long-term effect of heart defects.
    • Three defects rank among the most frequent causes of premature death due to congenital malformations; ventricular septal defect is one of them. The other 2 are hypoplastic left heart and transposition of the great arteries.
    • The direct and indirect costs are great. The economic cost to society remains difficult to delineate. For each infant or child who dies from complications of a ventricular septal defect, society is denied the fruit of his or her labor.
  • Points to remember
    • After a bicuspid aortic valve, ventricular septal defect is the most common congenital heart defect.
    • The axiom "the louder the murmur, the smaller the defect" does not always apply.
    • The murmurs heard in early infancy, which disappear by age 1 year, probably represent spontaneous closure of the defects.
    • Perimembranous defects account for 80% of all ventricular septal defects.
    • The recognition of the diastolic murmur of aortic insufficiency, in the presence of classic findings of ventricular septal defect, should make the diagnosis of supracristal variety likely.
    • The supracristal ventricular septal defect most commonly occurs in Asian patients.
    • The supracristal ventricular septal defect is also known as a doubly committed ventricular septal defect.
    • Elevated pulmonary resistance may be maintained in some patients despite therapy directed at the ventricular septal defect and may, in fact, represent a primary disease of the pulmonary vessels.
    • The defects observed in adulthood are usually small or medium sized because the vast majority of patients with isolated large defects come to medical and often surgical attention early in life.
    • An experienced pediatric cardiologist can accurately assess newly referred patients with murmurs on clinical examination with a sensitivity of 96% and a specificity of 95%.
 
Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous coauthors Ashmitha Srinivasan, BA; Viswanath Natesan, MD; and Sharmila Srinivasan, BS, to the development and writing of this article.



More on Ventricular Septal Defect, General Concepts

Overview: Ventricular Septal Defect, General Concepts
Differential Diagnoses & Workup: Ventricular Septal Defect, General Concepts
Treatment & Medication: Ventricular Septal Defect, General Concepts
Follow-up: Ventricular Septal Defect, General Concepts
Multimedia: Ventricular Septal Defect, General Concepts
References

References

  1. Roger H. Clinical researches on the congenital communication of the two sides of the heart by failure of occlusion of the interventricular septum. Bull de l' Acad de Med. 1879;8:1074.

  2. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. Sep 27 1958;755-62. [Medline].

  3. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. Oct 1958;18(4 Part 1):533-47. [Medline].

  4. Van Praagh R, Geva T, Kreutzer J. Ventricular septal defects: how shall we describe, name and classify them?. J Am Coll Cardiol. Nov 1 1989;14(5):1298-9. [Medline].

  5. Kidd L, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation. Feb 1993;87(2 Suppl):I38-51. [Medline].

  6. Wu MH, Wu JM, Chang CI, et al. Implication of aneurysmal transformation in isolated perimembranous ventricular septal defect. Am J Cardiol. Sep 1 1993;72(7):596-601. [Medline].

  7. Wu MH, Wang JK, Lin MT, et al. Ventricular septal defect with secondary left ventricular-to-right atrial shunt is associated with a higher risk for infective endocarditis and a lower late chance of closure. Pediatrics. Feb 2006;117(2):e262-7. [Medline].

  8. Rubin JD, Ferencz C, Loffredo C. Use of prescription and non-prescription drugs in pregnancy. The Baltimore-Washington Infant Study Group. J Clin Epidemiol. Jun 1993;46(6):581-9. [Medline].

  9. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol. Jan 17 2006;47(2):319-25. [Medline].

  10. Yip WC, Zimmerman F, Hijazi ZM. Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect. Catheter Cardiovasc Interv. Nov 2005;66(3):436-41. [Medline].

  11. Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. Nov 2008;136(5):1223-8. [Medline].

  12. Szkutnik M, Kusa J, Bialkowski J. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience. Kardiol Pol. Sep 2008;66(9):941-7; discussion 948-9. [Medline].

  13. Muller WH, Danimann JF. The treatment of certain congenital malformations of the heart by the creation of pulmonic stenosis to reduce pulmonary hypertension and excessive pulmonary blood flow; a preliminary report. Surg Gynecol Obstet. Aug 1952;95(2):213-9. [Medline].

  14. Lillehei CW, Cohen M, Warden HE. The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Surg Gynecol Obstet. Oct 1955;101(4):446-66. [Medline].

  15. Barratt-Boyes BG, Neutze JM, Clarkson PM, et al. Repair of ventricular septal defect in the first two years of life using profound hypothermia-circulatory arrest techniques. Ann Surg. Sep 1976;184(3):376-90. [Medline].

  16. Barratt-Boyes BG, Simpson M, Neutze JM, et al. Intracardiac surgery in neonates and infants using deep hypothermia with surface cooling and limited cardiopulmonary bypass. Circulation. May 1971;43(5 Suppl):I25-30. [Medline].

  17. Castaneda AR, Lamberti J, Sade RM, et al. Open-heart surgery during the first three months of life. J Thorac Cardiovasc Surg. Nov 1974;68(5):719-31. [Medline].

  18. Corone P, Doyon F, Gaudeau S, et al. Natural history of ventricular septal defect. A study involving 790 cases. Circulation. Jun 1977;55(6):908-15. [Medline].

  19. Pongiglione G, Freedom RM, Cook D, Rowe RD. Mechanism of acquired right ventricular outflow tract obstruction in patients with ventricular septal defect: an angiocardiographic study. Am J Cardiol. Oct 1982;50(4):776-80. [Medline].

  20. Zielinsky P, Rossi M, Haertel JC, et al. Subaortic fibrous ridge and ventricular septal defect: role of septal malalignment. Circulation. Jun 1987;75(6):1124-9. [Medline].

  21. Ando M, Sakai A, Nakamura K, et al. Infective endocarditis affecting both systemic and pulmonary circulations predisposed by a ventricular septal defect. Jpn J Thorac Cardiovasc Surg. Jul 2000;48(7):451-4. [Medline].

  22. Clark EB. Etiology of congenital cardiovascular malformations: epidemiology and genetics. In: Allen HD, Clark EB, Gutgesell HP, Driscoll DJ, eds. Moss and Adams' Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult. Vol 1. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:64-76.

  23. Cohle SD, Balraj E, Bell M. Sudden death due to ventricular septal defect. Pediatr Dev Pathol. Jul-Aug 1999;2(4):327-32. [Medline].

  24. Flyer DC. Ventricular septal defect. In: Nadas' Pediatric Cardiology. Philadelphia, PA: Hanley & Belfus; 1992:435-54.

  25. Gumbiner CH, Takao A. Ventricular septal defect. In: Bricker T, Fisher DJ, eds. The Science and Practice of Pediatric Cardiology. Vol 1. 2nd ed. Baltimore, MD: Lippincott Williams & Wilkins; 1997:1119-36.

  26. Jacobs JP, Burke RP, Quintessenza JA, Mavroudis C. Congenital Heart Surgery Nomenclature and Database Project: ventricular septal defect. Ann Thorac Surg. Apr 2000;69(4 Suppl):S25-35. [Medline].

  27. Johnson GL, Long WA. Diagnostic modalities: clinical examinations. In: Fetal and Neonatal Cardiology. Philadelphia, PA: WB Saunders; 1989.

  28. Kaplan S, Perloff JK. Exercise and athletics before and after cardiac surgery or interventional catheterization. In: Perloff JK, Child JS, eds. Congenital Heart Disease in Adults. 2nd ed. Philadelphia, PA: WB Saunders; 1998:189-98.

  29. Kirklin JW, DuShane JW. Repair of ventricular septal defect in infancy. Pediatrics. 1961;27:961.

  30. Miyaji K, Hannan RL, Ojito J, et al. Video-assisted cardioscopy for intraventricular repair in congenital heart disease. Ann Thorac Surg. Sep 2000;70(3):730-7. [Medline].

  31. Okamoto Y. [Clinical studies on open heart surgery in infants with profound hypothermia]. Nippon Geka Hokan. Jan 1 1969;38(1):188-207. [Medline].

  32. Perloff JK, Koos B. Pregnancy and congenital heart disease: the mother and the fetus. In: Perloff JK, Child JS, eds. Congenital Heart Disease in Adults. 2nd ed. Philadelphia, PA: WB Saunders; 1998:144-64.

  33. Smythe JF, Teixeira OH, Vlad P, et al. Initial evaluation of heart murmurs: are laboratory tests necessary?. Pediatrics. Oct 1990;86(4):497-500. [Medline].

  34. Sparkes RS, Perloff JK. Genetics, epidemiology, counseling, and prevention. In: Perloff JK, Child JS, eds. Congenital Heart Disease in Adults. 2nd ed. Philadelphia, PA: WB Saunders Co; 1998:165-85.

  35. Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring. Circulation. Feb 1993;87(2 Suppl):I89-101. [Medline].

Further Reading

Keywords

ventricular septal defect, VSD, isolated ventriculoseptal defect, isolated ventricular defect, maladie de Roger, Eisenmenger complex, Eisenmenger's syndrome, Eisenmenger syndrome, tetralogy of Fallot, TOF), complete atrioventricular canal defects, transposition of great arteries, corrected transpositions, cyanosis, hypertension, perimembranous ventricular septal defect, perimembranous VSD, conal septal, infundibular, subpulmonic, subarterial, subarterial doubly committed, outlet, supracristal ventricular septal defect, polycythemia, congestive heart failure, CHF, infective endocarditis, cardiomegaly, tachycardia, congenital cardiovascular malformations, CCVM, gestational diabetes mellitus

Contributor Information and Disclosures

Author

Prema Ramaswamy, MD, Assistant Professor of Pediatrics, Mount Sinai School of Medicine of New York University; Adjunct Assistant Clinical Professor of Pediatrics, St George's University School of Medicine; Co-Director of Pediatric Cardiology, Maimonides Medical Center, Lutheran Medical Center, and Coney Island Hospital
Prema Ramaswamy, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Cardiology
Disclosure: Nothing to disclose.

Coauthor(s)

Patturajah Anbumani, MD, MBBS, MS, MCh, Associate Medical Director, Best Medical Care; Former Associate Medical Director, Jeanes Hospital, Temple University Health System; Former Adjunct Clinical Assistant Professor, New York College of Osteopathic Medicine; Former Clinical Assistant Professor, Department of Medicine, State University of New York-Downstate
Patturajah Anbumani, MD, MBBS, MS, MCh is a member of the following medical societies: American College of Physicians, American Medical Association, and American Medical Women's Association
Disclosure: Nothing to disclose.

Kuruchi Srinivasan, MD, Consulting Staff, Department of Internal Medicine, Nazareth Hospital
Kuruchi Srinivasan, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Jeffrey Allen Towbin, MD, MSc, FAAP, FACC, FAHA, Professor, Departments of Pediatrics (Cardiology), Cardiovascular Sciences, and Molecular and Human Genetics, Baylor College of Medicine; Chief of Pediatric Cardiology, Foundation Chair in Pediatric Cardiac Research, Texas Children's Hospital
Jeffrey Allen Towbin, MD, MSc, FAAP, FACC, FAHA is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American College of Cardiology, American College of Sports Medicine, American Heart Association, American Medical Association, American Society of Human Genetics, Cardiac Electrophysiology Society, New York Academy of Sciences, Society for Pediatric Research, Texas Medical Association, and Texas Pediatric Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Hugh D Allen, MD, Professor, Department of Pediatrics, Division of Pediatric Cardiology and Department of Internal Medicine, Ohio State University College of Medicine
Hugh D Allen, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, American Society of Echocardiography, Society for Pediatric Research, Society of Pediatric Echocardiography, and Western Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Gilbert Z Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College; Consulting Staff, Department of Pediatrics, Sound Shore Medical Center
Gilbert Z Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD, Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin
Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.